Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$13.00 -0.20 (-1.52%)
As of: Oct 22, 2026 · 10:40 AM EDT

Eloxx Pharmaceuticals (ELOX) Receivables - Net (2014)

Updated

Eloxx Pharmaceuticals (ELOX) reported Receivables - Net of $203,915 for Q2 2015, up 372.8% from the prior quarter.

Analysis

Eloxx Pharmaceuticals (ELOX) Receivables - Net (2014) Analysis & Trends

At the end of FY2014, Eloxx Pharmaceuticals posted Receivables - Net of $43,133.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.78 Bn 1,135.37 Bn 19.71 Bn
2 Johnson & Johnson 635.34 Bn 553.86 Bn 17.26 Bn
3 AbbVie 503.48 Bn 476.60 Bn 12.70 Bn
4 Merck 377.08 Bn 331.46 Bn 12.21 Bn
5 Novartis Ag 304.13 Bn 268.12 Bn 11.24 Bn
6 Astrazeneca 267.48 Bn 241.16 Bn 12.86 Bn
7 Amgen 241.75 Bn 197.15 Bn 7.24 Bn
8 Gilead Sciences 194.09 Bn 168.29 Bn 6.22 Bn
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn
10 Eloxx Pharmaceuticals 88.26 Mn 14.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 203,915.00
Sep 30, 2014 43,133.00
Jun 30, 2014 43,133.00
API Access

Eloxx Pharmaceuticals Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=ELOX&period=max&api_key=YOUR_API_KEY